ReviewNaunyn-Schmiedeberg's archives of pharmacology2025

Unlocking the potential of THR-β agonist therapies: resmetirom's chemistry, biology, and patent insights.

Khushi Dahiya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.